DESCRIPTION

This blog does not intend to discuss indication or project specific elements such as Clinical Development or Regulatory Strategies. These are important aspects of Clinical Research Management and key for the overall success. However, they are usually not generalizable and typically considered confidential.

The ability to execute efficiently, however, is the underlying key to success as measured by timelines, budget and quality - especially in small and virtual biotech companies.

This blog attempts to make a difference by focusing on those generic aspects of Clinical Research Management that go across indications, clinical development stages and trial complexity. They are in one way or another relevant to almost any clinical research project.

This blog has the scope to support small and virtual teams handling the challenges of managing the outsourcing of complex clinical projects without a lot of organizational support.

In small and virtual biotech execution risk is the greatest risk. This is why I call the blog "Advanced Clinical Research Management"

Sunday, May 6, 2012

How to start building vendor relationships


Over the years, I have prioritized the importance of meeting a wide range of potential vendors early in your planning stages.

When you work in a virtual biotech organization, you only have access to a very small team and vendor interaction becomes a key resource.

In the process you identify your needs, shape your outsourcing strategy, and understand which capabilities are available with your potential future partner(s) - and most importantly - which NOT.

In my experience, it is vital to understand which capabilities are NOT available when you contract a vendor. No single vendor can offer you the entire breadth of activities at the level of experience and professionalism that you may need - although they typically will claim they can.

Further down the road - after you have contracted your vendors and kicked-off the project - it is what they can NOT do that leads to additional resource requirements and delays...

By understanding what you can NOT expect from your vendor - enables you to manage the shortcomings proactively.

Conferences like "Outsourcing in Clinical Trials", "DIA", "Biotech Clinical Outsourcing Partnerships", "Partnerships in Clinical Trials" etc. provide you with a great opportunity to scan the market for vendors, to evaluate a potential fit for your current needs and to make decisions about who you want to continue to interact with.

In this way you can reduce the amount of Business Development meetings at your office - not to forget the amount of requests for meetings by Business Development staff every month.

No comments:

Post a Comment